missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CDw293 Polyclonal Antibody, Invitrogen™
Rabbit Polyclonal Antibody
Brand: Invitrogen 409400
This item is not returnable.
View return policy
Description
BMPR1B (also known as ALK6, CDw293) is a member of the transmembrane serine/threonine kinase that is the member of the bone morphogenetic protein (BMP) receptor, which is closely related to the activin receptors, ACVR1 and ACVR2. BMPR1B is mainly involved in the endochondral bone formation and embryogenesis. BMPR1B expressed in normal and cancerous prostate tissues and used in the endocrine therapy that given to the prostate cancer patients. BMPR1B receptor trafficking also play a significant role in FOP pathogenesis and used in human T-cell differentiation.
Specifications
| CDw293 | |
| Polyclonal | |
| Unconjugated | |
| BMPR1B | |
| Activin receptor-like kinase 6; Acvrlk6; AI385617; Alk6; ALK-6; AMDD; AV355320; BDA1D; BDA2; BMP type-1B receptor; BMP15; Bmpr1b; BMPR-1B; BMPRIB; BMPR-IB; bone morphogenetic protein binding serine/threonine kinase receptor; bone morphogenetic protein receptor IB; bone morphogenetic protein receptor type 1B; bone morphogenetic protein receptor type IB; bone morphogenetic protein receptor type-1B; bone morphogenetic protein receptor, type 1B; bone morphogenetic protein receptor, type IB; CDw293; CFK-43a; serine/threonine receptor kinase; serine/threonine-protein kinase receptor R6; SKR6 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 12167, 310914, 658 | |
| -20°C | |
| Liquid |
| Western Blot | |
| 0.25 mg/mL | |
| PBS with 0.1% sodium azide; pH 7.4 | |
| O00238, P36898 | |
| BMPR1B | |
| Synthetic peptide derived from the C-terminal region of the human, mouse, rat, sheep, pig, and goat BMPR-1B proteins | |
| 100 μg | |
| Primary | |
| Human, Mouse, Rat | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction